Advertisement

Pituitary

, Volume 18, Issue 4, pp 448–455 | Cite as

Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors

  • J. Ratnasingam
  • N. Karim
  • S. S. Paramasivam
  • L. Ibrahim
  • L. L. Lim
  • A. T. B. Tan
  • S. R. Vethakkan
  • A. Jalaludin
  • S. P. Chan
Article

Abstract

Purpose

Radiation fields for nasopharyngeal cancer (NPC) include the base of skull, which places the hypothalamus and pituitary at risk of damage. We aimed to establish the prevalence, pattern and severity of hypothalamic pituitary (HP) dysfunction amongst NPC survivors.

Methods

We studied 50 patients (31 males) with mean age 57 ± 12.2 years who had treatment for NPC between 3 and 21 years (median 8 years) without pre-existing HP disorder from other causes. All patients had a baseline cortisol, fT4, TSH, LH, FSH, oestradiol/testosterone, prolactin and renal function. All patients underwent dynamic testing with insulin tolerance test to assess the somatotroph and corticotroph axes. Baseline blood measurements were used to assess thyrotroph, gonadotroph and lactotroph function.

Results

Hypopituitarism was present in 82 % of patients, 30 % single axis, 28 % two axes, 18 % three axes and 6 % four axes deficiencies. Somatotroph deficiency was most common (78 %) while corticotroph, gonadotroph and thyrotroph deficiencies were noted in 40 % (4 complete/16 partial), 22 and 4 % of the patients respectively. Hyperprolactinaemia was present in 30 % of patients. The development of HP dysfunction was significantly associated with the time elapsed from irradiation, OR 2.5 (1.2, 5.3), p = 0.02, for every 2 years post treatment. The use of concurrent chemo-irradiation (CCRT) compared to those who had radiotherapy alone was also significantly associated with HP dysfunction, OR 14.5 (2.4, 87.7), p < 0.01.

Conclusion

Despite low awareness and detection rates, HP dysfunction post-NPC irradiation is common. Use of CCRT may augment time related pituitary damage. As these endocrinopathies result in significant morbidity and mortality we recommend periodic assessment of pituitary function amongst NPC survivors.

Keywords

Nasopharyngeal cancer Hypothalamic-pituitary dysfunction Radiotherapy Concurrent chemo-irradiation GH deficiency Panhypopituitarism 

Notes

Acknowledgments

The authors would like to acknowledge the Late Professor Rokiah Pendek, who continues to be our inspiration to strive for excellence. The study was supported by the University Malaya Research Grant (UMRG), UMRG 255/10 HTM.

Conflict of interest

The authors declare that they have no conflict of interests.

References

  1. 1.
    Al-Sarraf M, LeBlanc M, Giri PG (1998) Superiority of five year survival with chemo-radiotherapy vs. radiotherapy in patients with locally advanced NPC: phase III randomised Intergroup study 0099. J Clin Oncol 16(4):1310–1317PubMedGoogle Scholar
  2. 2.
    Prabakar VKB, Shalet SM (2006) Aetiology, diagnosis and management of hypopituitarism in adult life. Postgrad Med J 82:259–26610CrossRefGoogle Scholar
  3. 3.
    Darzy KH, Shalet SM (2006) Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 8:203–211CrossRefGoogle Scholar
  4. 4.
    Endocrine deficit after fractionated total body irradiation, Ogilvy-Stuart AL, Clark DJ, Wallace WH, Gibson BE, Stevens RF, Shalet SM, Donaldson MD (1992) Endocrine deficit after fractionated total body irradiation. Arch Dis Child 67:1107–1110CrossRefGoogle Scholar
  5. 5.
    Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall M, Yasui Y, Nicholson HS, Wolden S, McNeil DE, Mertens AC, Robinson LL (2003) Endocrine and cardiovascular late effects among adult survivors of childhood brain tumours. Childhood Cancer Survivor Study. Cancer 97:663–673PubMedCrossRefGoogle Scholar
  6. 6.
    Brauner R, Rappaport R, Pevot C, Czernichow P, Zucker JM, Bataini P, Lemerle J, Sarrazin D, Guyda HJ (1989) A prospective study of development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab 68:346–351PubMedCrossRefGoogle Scholar
  7. 7.
    Appelman-Djikstra N, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, Romjin JA, Smit JWA, Pereira AM (2011) Pituitary dysfunction in adult patients after cranial radiotherapy : systemic review and meta-analysis. J Clin Endocrinol Metab 96(8):2330–2340CrossRefGoogle Scholar
  8. 8.
    Lam KSL, Tse VK, Wang CI, Yeung RTT, Ho JHC (1991) Effects of cranial irradiation on hypothalamic pituitary function—a five year longitudinal study in patients with naso-pharyngeal carcinoma. Q J Med 78(286):165–167PubMedGoogle Scholar
  9. 9.
    Growth Hormone Research Society (1998) (GRS): consensus guidelines for the diagnosis and treatment of adults with GH deficiency. Statement of the GRS workshop on adult GHD. J Clin Endocrinol Metab 83:379–381Google Scholar
  10. 10.
    Hoffman DM, O’Sullivan AJ, Baxter RC, Ho KKY (1994) Diagnosis of growth hormone deficiency in adults. Lancet 343:1064–1068PubMedCrossRefGoogle Scholar
  11. 11.
    Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo F (1998) Comparison between insulin induced hypoglycaemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:16151618Google Scholar
  12. 12.
    Plumpton FS, Besser GM (1969) The adrenocortical response to surgery and insulin induced hypoglycaemia in corticosteroid treated and normal subjects. Br J Surg 56:216–219PubMedCrossRefGoogle Scholar
  13. 13.
    Schneider HJ, Aimaretti G, Andermahr IK, Stalla GK, Ghigo E (2007) Hypopituitarism. Lancet 369:1461–1470PubMedCrossRefGoogle Scholar
  14. 14.
    Trainer PJ, Besser GM (1995) The barts protocol Churchill Livingstone 1,4-1123Google Scholar
  15. 15.
    Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G, Beck-Peccoz P (1999) Evaluation of the adequacy of levo-thyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84:924–929PubMedGoogle Scholar
  16. 16.
    Darzy KH, Shalet SM (2005) Hypopituitarism after cranial irradiation. J Endocrinol Invest 28:78–87PubMedGoogle Scholar
  17. 17.
    Brennan BM, Rahim A, Mackie EM, Eden OB, Shalet SM (1998) Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf) 48(6):777–783CrossRefGoogle Scholar
  18. 18.
    Toogood AA (2004) Endocrine consequences of brain irradiation. Growth Horm IGF Res 14(SupplA):S118–S124Google Scholar
  19. 19.
    Arlt W, Hove U, Muller B (1997) Frequent and frequently overlooked: treatment induced endocrine dysfunction in adult long term survivors of primary brain tumours. Neurology 149(2):498–506CrossRefGoogle Scholar
  20. 20.
    Agha A, Sherlock M, Brennan S, O’Connor SA, O’sullivan E, Rogers B, Faul C, Rawluk D, Tormey W, Thompson CJ (2005) Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 90:6355–6360PubMedCrossRefGoogle Scholar
  21. 21.
    Bates AS, Van’t HW, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81:1169–1172PubMedGoogle Scholar
  22. 22.
    Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML (1989) Hypopituitarism following external radiotherapy for pituitary tumors in adults. Q J Med 70:145–160PubMedGoogle Scholar
  23. 23.
    Taphoorn MJ, Heimans JJ, van der Veen EA, Karim AB (1995) Endocrine functions in long term survivors of low grade supratentorialglioma treated with radiation therapy. J Neurooncol 25:97–102PubMedCrossRefGoogle Scholar
  24. 24.
    Rosenthal MB, Goldfine ID (1976) Primary and secondary hypothyroidism in nasopharyngeal carcinoma. JAMA 236:1591–1593PubMedCrossRefGoogle Scholar
  25. 25.
    Lin Z, Wu VW, Lin J, Feng H, Chen L (2011) A longitudinal study on radiation induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid 21:19–23PubMedCrossRefGoogle Scholar
  26. 26.
    Dent P, Yacoub A, Contessa J (2003) Stress and radiation—induced activation of multiple intracellular signalling pathways. Radiat Res 159:283–300PubMedCrossRefGoogle Scholar
  27. 27.
    Shalet SM, Beardwall CG, Pearson D, Jones PH (1976) The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol Oxf 5:287–290PubMedCrossRefGoogle Scholar
  28. 28.
    Samaan NA, Bakdash MM, Caderao JB, Cangir A, Jesse RH Jr, Ballantyne AJ (1975) Hypopituitarism after external irradiation: Evidence for both hypothalamic and pituitary origin. Ann Intern Med 83:771–777PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • J. Ratnasingam
    • 1
  • N. Karim
    • 1
  • S. S. Paramasivam
    • 1
  • L. Ibrahim
    • 1
  • L. L. Lim
    • 1
  • A. T. B. Tan
    • 1
  • S. R. Vethakkan
    • 1
  • A. Jalaludin
    • 2
  • S. P. Chan
    • 1
  1. 1.Endocrine Unit, Department of MedicineUniversity Malaya Medical CentreKuala LumpurMalaysia
  2. 2.Department of OtorhinolaryngologyUniversity Malaya Medical CentreKuala LumpurMalaysia

Personalised recommendations